(N)-Methanocarba adenosine 5′-methyluronamides containing known A3 AR (adenosine receptor)-enhancing modifications, ie, 2-(arylethynyl) adenine and N 6-methyl or N 6-(3- substituted-benzyl), were nanomolar full agonists of human (h) A3AR and highly selective (K i∼ 0.6 nM, N 6-methyl 2-(halophenylethynyl) analogues 13 and 14). Combined 2- arylethynyl-N 6-3-chlorobenzyl substitutions preserved A3AR affinity/selectivity in the (N)- ...
[Foroozesh, Maryam; Primrose, Ginny; Guo, Zuyu; Bell, L. Chastine; Alworth, William L.; Guengerich, F. Peter Chemical Research in Toxicology, 1997 , vol. 10, # 1 p. 91 - 102]
[Filichev, Vyacheslav V.; Astakhova, Irina V.; Malakhov, Andrei D.; Korshun, Vladimir A.; Pedersen, Erik B. Chemistry - A European Journal, 2008 , vol. 14, # 32 p. 9968 - 9980]